Navigation Links
MedQuist Performance Monitor Offers Transparency, Detailed Reporting and Measurement of Clinical Documentation Metrics
Date:2/24/2010

MT. LAUREL, N.J., Feb. 24 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of technology-enabled clinical documentation services, has introduced the MedQuist Performance Monitor (MPM). The MPM reporting tool provides MedQuist customer facilities with physician, worktype and facility detailed reporting to monitor, track and optimize their clinical reporting process. The MPM offers a value-added benefit for transcription outsourcing customers who use the DocQment® Enterprise Platform, and is robust and relevant enough to meet The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) standards.

As a reporting tool, the MPM produces meaningful, actionable information, including turnaround time (TAT) compliance, worktype and dictator statistics, performance trends, and quality indicators. Key features and benefits include:

  • Metrics that can be used to track and manage clinical reporting performance, provide summary reports to management, and obtain data required by The Joint Commission.
  • Critical areas tracked:
    • TAT compliance -- absolute and average by volume, by worktype and by dictator, and an "early/late" view that is unique in the industry
    • Quality Indicator -- "blanks" reporting ratio
    • Documentation and author input deficiencies
    • Physician performance and compliance
  • Measureable, quantifiable data that is displayed in both graph and chart formats for easy interpretation and continuous improvement.

MedQuist Chief Operating Officer Michael Clark notes, "Consistent with MedQuist's leadership in driving toward transparency within the industry, customers who contract with us for transcription work can see, clearly and concisely, how their outsourced service and physicians are performing. MedQuist's assigned Customer Care Managers review the MPM reports with their customers on a regular basis, and offer best practices, continuous process improvement advice, information and tools to help maximize document quality, data efficiency, and service delivery consistency and compliance, for optimal patient care."

For more information on the MedQuist Performance Monitor or to see sample reports, please visit www.medquist.com.

About MedQuist

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE MedQuist

Back to top

RELATED LINKS
http://www.medquist.com

'/>"/>

SOURCE MedQuist
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedQuist Announces Reseller Agreement With Clario
2. MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention
3. MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties
4. MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology
5. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
6. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
7. Artists for a New South Africa Will be Shaking The Blues at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb Mo, Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles
8. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
9. Evotecs EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks
10. SPIRIT II Explores Long-Term Performance of XIENCE V Stent
11. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):